Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Bleomycin Therapy in Mycosis fungoides
View through CrossRef
Nine patients with mycosis fungoides in different stages were treated with Bleomycin. Much better results were obtained with this new drug in the six patients with the infiltrative or beginning tumour stage than in the patients in the advanced tumour stage. Complete remission was not seen. In one case the results were objectivized by DNA cytophotometry. The role of Bleomycin in the treatment of mycosis fungoides is discussed. It is concluded that Bleomycin is not the medicament of choice for the treatment of mycosis fungoides.
Title: Bleomycin Therapy in Mycosis fungoides
Description:
Nine patients with mycosis fungoides in different stages were treated with Bleomycin.
Much better results were obtained with this new drug in the six patients with the infiltrative or beginning tumour stage than in the patients in the advanced tumour stage.
Complete remission was not seen.
In one case the results were objectivized by DNA cytophotometry.
The role of Bleomycin in the treatment of mycosis fungoides is discussed.
It is concluded that Bleomycin is not the medicament of choice for the treatment of mycosis fungoides.
Related Results
Thyroid Dysfunction in Mycosis Fungoides: Sonographic and Laboratory Insights
Thyroid Dysfunction in Mycosis Fungoides: Sonographic and Laboratory Insights
Introduction: Thyroid gland affection in mycosis fungoides has been rarely reported. It occurs as extracutaneous involvement, incidentally, as a second malignancy, or as a side eff...
Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51
Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51
Abstract
Background
Bleomycin, a potent antitumor agent, is limited in clinical use due to the potential for fatal pulmonary toxicity. The accelerat...
CD4/CD8 double-negative mycosis fungoides: a review
CD4/CD8 double-negative mycosis fungoides: a review
Mycosis Fungoides (MF) stands as the predominant form of primary cutaneous T-cell lymphoma (CTCL). It manifests a diverse array of clinical, histological, and immunophenotypic vari...
A Novel Compound Sclerosant: Polidocanol–Bleomycin Foam
A Novel Compound Sclerosant: Polidocanol–Bleomycin Foam
BACKGROUND
Foam sclerotherapy is an effective treatment strategy for venous malformations. Both polidocanol (POL) and bleomycin are effective sclerosants; howev...
Effect of OTR4120 on pulmonary fibrosis
Effect of OTR4120 on pulmonary fibrosis
Abstract
Background
Acute respiratory distress syndrome (ARDS) can be related to airway remodeling caused by pulmonary fibrosis...
Pediatric Hypopigmented Mycosis Fungoides: A Narrative Literature Review of Phototherapy Dosing Regimens
Pediatric Hypopigmented Mycosis Fungoides: A Narrative Literature Review of Phototherapy Dosing Regimens
Background
Mycosis fungoides is the most common type of childhood‐onset primary cutaneous T‐cell lymphoma, and hypopigmented mycosis fungoides (hMF) is a rare, ...
Mycosis Fungoides: A differential diagnosis to consider for lichenoid keratosis
Mycosis Fungoides: A differential diagnosis to consider for lichenoid keratosis
Mycosis fungoides (MF) has a wide spectrum of presentation. Its clinic is polymorphic, leading to several clinical variants. Chronic diffuse hyperpigmented lesions can be found in ...
Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
AbstractBackgroundFolliculotropic mycosis fungoides (FMF) is a rare variant of mycosis fungoides with clinical peculiarities, refractoriness to conventional treatments, and worse p...